Back to search
Leber Congenital Amaurosis (LCA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Leber Congenital Amaurosis (LCA) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Leber Congenital Amaurosis (LCA) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this double-masked, randomized, placebo-controlled, paired-eye study is to evaluate the efficacy, safety and tolerability of Sepofarsen in subjec…
The purpose of the study is to determine whether HG004 as gene therapy is safe and effective for the treatment of Leber Congenital Amaurosis caused by mutations…
The objectives of this study are to evaluate the effect of a group psychotherapy intervention for parents of children/adolescents with LCA on indicators of emot…
The objective of this study is to collect long-term safety information (i.e., for 5 years after treatment) associated with voretigene neparvovec-rzyl (vector an…